Who Paid My Doc
Farid Sadaka
Critical Care Medicine Saint Louis, MO Medical Doctor
NPI 1144337411 CMS profile 143072
621 S New Ballas Rd, Suite 4006-B, Saint Louis, MO 63141
General payments
$41,153
Research payments
$12,313
Ownership & investment interest
$0
Research they led as principal investigator
$559,277
Through program year 2025, Farid Sadaka of Saint Louis, MO is reported in the CMS Open Payments database as having received $41,153 across 15 general payments and $12,313 in research payments paid to them. Separately, studies naming them as principal investigator received $559,277 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $28 | 1 | |
| 2024 | General | $16 | 1 | |
| 2023 | General | $1,975 | 1 | |
| 2022 | General | $38,678 | 11 | |
| 2021 | Research | $12,313 | 1 | |
| 2019 | General | $456 | 1 |
Beside peers
- Farid Sadaka
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Farid Sadaka were reported at $28. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.
Show as a table
| Year | Farid Sadaka | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $456 | $149 | $51–$535 | $163 |
| 2020 | $0 | $110 | $30–$325 | $114 |
| 2021 | $0 | $125 | $34–$403 | $132 |
| 2022 | $38,678 | $157 | $49–$582 | $149 |
| 2023 | $1,975 | $162 | $56–$621 | $160 |
| 2024 | $16 | $168 | $53–$634 | $164 |
| 2025 | $28 | $189 | $59–$844 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$29,959
Medicare patients
86
Services billed
220
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Heart failure | 63% | |
| Chronic kidney disease | 60% | |
| Arthritis | 59% | |
| Ischemic heart disease | 56% | |
| Diabetes | 50% | |
| COPD | 49% | |
| Atrial fibrillation | 44% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
16 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Critical Care Medicine in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.